Citigroup’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-73,319
| Closed | -$15.9M | – | 6603 |
|
|
2021
Q1 | $15.9M | Buy |
73,319
+40,017
| +120% | +$7.52M | 0.01% | 1086 |
|
|
2020
Q4 | $3.84M | Sell |
33,302
-856
| -3% | -$95.9K | ﹤0.01% | 2278 |
|
|
2020
Q3 | $3.33M | Buy |
34,158
+6,575
| +24% | +$757K | ﹤0.01% | 2208 |
|
|
2020
Q2 | $3.38M | Sell |
27,583
-775
| -3% | -$87.9K | ﹤0.01% | 2232 |
|
|
2020
Q1 | $2.48M | Sell |
28,358
-6,513
| -19% | -$690K | ﹤0.01% | 2280 |
|
|
2019
Q4 | $3.65M | Buy |
34,871
+15,170
| +77% | +$1.7M | ﹤0.01% | 2319 |
|
|
2019
Q3 | $2.27M | Buy |
19,701
+6,965
| +55% | +$1.06M | ﹤0.01% | 2720 |
|
|
2019
Q2 | $2.2M | Sell |
12,736
-3,902
| -23% | -$675K | ﹤0.01% | 2752 |
|
|
2019
Q1 | $2.81M | Sell |
16,638
-1,601
| -9% | -$238K | ﹤0.01% | 2309 |
|
|
2018
Q4 | $1.78M | Buy |
18,239
+5,783
| +46% | +$759K | ﹤0.01% | 2778 |
|
|
2018
Q3 | $2.15M | Sell |
12,456
-1,582
| -11% | -$228K | ﹤0.01% | 2672 |
|
|
2018
Q2 | $1.96M | Sell |
14,038
-16,543
| -54% | -$2.35M | ﹤0.01% | 2696 |
|
|
2018
Q1 | $3.45M | Buy |
30,581
+27,716
| +967% | +$3.48M | ﹤0.01% | 2116 |
|
|
2017
Q4 | $378K | Sell |
2,865
-3,046
| -52% | -$358K | ﹤0.01% | 4402 |
|
|
2017
Q3 | $600K | Buy |
5,911
+97
| +2% | +$10.4K | ﹤0.01% | 3926 |
|
|
2017
Q2 | $583K | Sell |
5,814
-69,905
| -92% | -$7.52M | ﹤0.01% | 3847 |
|
|
2017
Q1 | $9.16M | Buy |
75,719
+11,162
| +17% | +$1.37M | 0.01% | 1195 |
|
|
2016
Q4 | $7.21M | Buy |
64,557
+57,264
| +785% | +$6.89M | 0.01% | 1475 |
|
|
2016
Q3 | $968K | Sell |
7,293
-22,909
| -76% | -$2.19M | ﹤0.01% | 3259 |
|
|
2016
Q2 | $2.77M | Buy |
30,202
+26,042
| +626% | +$2.19M | ﹤0.01% | 2084 |
|
|
2016
Q1 | $300K | Sell |
4,160
-1,494
| -26% | -$82K | ﹤0.01% | 4690 |
|
|
2015
Q4 | $393K | Sell |
5,654
-4,194
| -43% | -$342K | ﹤0.01% | 4110 |
|
|
2015
Q3 | $900K | Buy |
9,848
+4,645
| +89% | +$516K | ﹤0.01% | 3189 |
|
|
2015
Q2 | $639K | Buy |
5,203
+1,456
| +39% | +$165K | ﹤0.01% | 3486 |
|
|
2015
Q1 | $342K | Sell |
3,747
-829
| -18% | -$67.3K | ﹤0.01% | 4079 |
|
|
2014
Q4 | $309K | Buy |
4,576
+2,805
| +158% | +$205K | ﹤0.01% | 4328 |
|
|
2014
Q3 | $143K | Sell |
1,771
-3,485
| -66% | -$308K | ﹤0.01% | 4463 |
|
|
2014
Q2 | $563K | Buy |
5,256
+3,997
| +317% | +$278K | ﹤0.01% | 3390 |
|
|
2014
Q1 | $75K | Buy |
1,259
+1,241
| +6,894% | +$73.8K | ﹤0.01% | 5220 |
|
|
2013
Q4 | $1K | Buy |
+18
| New | +$569 | ﹤0.01% | 6897 |
|
Other funds holding GWPH
Citigroup's GWPH Position: Q2 2021 in Review
Citigroup sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 73,319 shares — an estimated $15.9M sold.
Citigroup first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $15.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Citigroup reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Citigroup sold 73,319 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $15.9M.
- Citigroup first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
- Citigroup's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.9M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.